Racial disparities in chronic total occlusion percutaneous coronary interventions: insights from the PROGRESS-CTO registry.

CTO-PCI major adverse cardiac events racial disparity in healthcare

Journal

The Journal of invasive cardiology
ISSN: 1557-2501
Titre abrégé: J Invasive Cardiol
Pays: United States
ID NLM: 8917477

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 5 3 2024
pubmed: 5 3 2024
entrez: 5 3 2024
Statut: ppublish

Résumé

There is limited data on race and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). The authors sought to evaluate CTO PCI techniques and outcomes in different racial groups. We examined the baseline characteristics and procedural outcomes of 11 806 CTO PCIs performed at 44 US and non-US centers between 2012 and March 2023. In-hospital major adverse cardiac events (MACE) included death, myocardial infarction, repeat target-vessel revascularization, pericardiocentesis, cardiac surgery, and stroke prior to discharge. The most common racial group was White (84.5%), followed by Black (5.7%), "Other" (3.9%), Hispanic (2.9%), Asian (2.4%), and Native American (0.7%). There were significant differences in the baseline characteristics between different racial groups. When compared with non-White patients, the retrograde approach and antegrade dissection re-entry were more likely to be the successful crossing strategies in White patients without any significant differences in technical success (86.4% vs 86.4%; P = .93), procedural success (84.8% vs 85.0%; P = .79), and in-hospital MACE (2.0% vs 1.5%; P = .15) between the 2 groups. The technical success rate was significantly higher in the "Other" racial group (91.0% vs 86.4% in White, 86.9% in Asian, 84.5% in Black, 84.5% in Hispanic, and 83.3% in Native American; P = .03) without any significant differences in procedural success or in-hospital MACE rates between the groups. Despite differences in baseline characteristics and procedural techniques, the procedural success and in-hospital MACE of CTO PCI were not significantly different between most racial groups.

Identifiants

pubmed: 38441989
doi: 10.25270/jic/23.00274
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Salman S Allana (SS)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA; UT Southwestern Medical Center, Dallas, Texas, USA.

Athanasios Rempakos (A)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Michaella Alexandrou (M)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Deniz Mutlu (D)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Khaldoon Alaswad (K)

Henry Ford Cardiovascular Division, Detroit, Michigan, USA.

Lorenzo Azzalini (L)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Kathleen Kearney (K)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Oleg Krestyaninov (O)

Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dmitrii Khelimskii (D)

Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.

Sevket Gorgulu (S)

Acibadem Kocaeli Hospital, Izmit, Turkey.

Raj Chandwaney (R)

Oklahoma Heart Institute, Tulsa, Oklahoma, USA.

Farouc A Jaffer (FA)

Massachusetts General Hospital, Boston, Massachusetts, USA.

Jaikirshan J Khatri (JJ)

Cleveland Clinic, Cleveland, Ohio, USA.

Rhian Davies (R)

Wellspan York Hospital, York, Pennsylvania, USA.

Stewart Benton (S)

Wellspan York Hospital, York, Pennsylvania, USA.

James W Choi (JW)

Texas Health Presbyterian Hospital, Dallas, Texas, USA.

Dimitrios Karmpaliotis (D)

Gagnon Cardiovascular Institute, Morristown Medical Center, New Jersey, USA.

Paul Poommipanit (P)

University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

William Nicholson (W)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Wissam Jaber (W)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Stephane Rinfret (S)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Jarrod Frizzell (J)

Christ Hospital, Cincinnati, Ohio, USA.

Taral Patel (T)

HonorHealth Heart Group Shea, Scottsdale, Arizona, USA.

Brian Jefferson (B)

HonorHealth Heart Group Shea, Scottsdale, Arizona, USA.

Nazif Aygul (N)

Selcuk University, Konya, Turkey.

Omer Goktekin (O)

Memorial Bahcelievler Hospital, Istanbul, Turkey.

Ahmed ElGuindy (A)

Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt.

Nidal Abi-Rafeh (N)

North Oaks Health System, Hammond, Louisiana, USA.

Bavana V Rangan (BV)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bilal Murad (B)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

M Nicholas Burke (MN)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Email: esbrilakis@gmail.com.

Classifications MeSH